Biotech Values

[DragonBits]

Thoughts on Misonix HIFU technology?

Misonix has an ultrasonic platform used for wound debridement, cosmetic surgery, neurosurgery.

They sell their Sonablate® 500 High Intensity Focused Ultrasound (HIFU) System, mostly for prostate cancer removal. Misonix has rights in Europe, Eastern Europe & Russia. I like the fact that they can destroy prostate (and other cancers) cancers without any sort of invasive surgery.

Their Wound Debridement (UWD) system is probably a bigger deal for Misonix, but the Sonablate® 500 is appealing to me. Kidney Cancer I think might get approved in Sept.

I bought in around 90 cents, so at $2.40 I am happy, and I think the company should be worth at least 5-7 in a buyout right now. Just a rough guess, and doesn’t include any increased revenue or approvals. Sold a little at 2.50 – 2.90 just to lower my relative weighting, and the stock is so thin that I wanted to be more flexible. Currently without new news, I guess the stock will stay between 2.00 and 2.90.

Here is one of their lastest presentations.

http://library.corporate-ir.net/library/11/117/117022/items/318295/%7B834D7BBE-F002-466E-9535-9F934A16DB4C%7D_MSON_R&R_Conference.pdf

Any thought on this company or technology?